Article Versions Notes

Imai H, Kaira K, Endoh H, Imaizumi K, Goto Y, Kamiyoshihara M, Kosaka T, Yajima T, Ohtaki Y, Osaki T, et al. Prognostic Significance of Glucose Metabolism as GLUT1 in Patients with Pulmonary Pleomorphic Carcinoma. Journal of Clinical Medicine. 2020; 9(2):413. https://doi.org/10.3390/jcm9020413

Imai, Hisao, Kyoichi Kaira, Hideki Endoh, Kazuyoshi Imaizumi, Yasuhiro Goto, Mitsuhiro Kamiyoshihara, Takayuki Kosaka, Toshiki Yajima, Yoichi Ohtaki, Takashi Osaki, and et al. 2020. "Prognostic Significance of Glucose Metabolism as GLUT1 in Patients with Pulmonary Pleomorphic Carcinoma" Journal of Clinical Medicine 9, no. 2: 413. https://doi.org/10.3390/jcm9020413

Imai, H., Kaira, K., Endoh, H., Imaizumi, K., Goto, Y., Kamiyoshihara, M., Kosaka, T., Yajima, T., Ohtaki, Y., Osaki, T., Kogure, Y., Tanaka, S., Fujita, A., Oyama, T., Minato, K., Asao, T., & Shirabe, K. (2020). Prognostic Significance of Glucose Metabolism as GLUT1 in Patients with Pulmonary Pleomorphic Carcinoma. Journal of Clinical Medicine, 9(2), 413. https://doi.org/10.3390/jcm9020413